Pefloxacin
From Wikipedia, the free encyclopedia
 |
|
|
Pefloxacin
|
|
| Systematic (IUPAC) name | |
| 1-ethyl-6-fluoro-7- (4-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H20FN3O3 |
| Mol. mass | 333.358 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 20-30% |
| Metabolism | ? |
| Half life | 8.6 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Pefloxacin is a fluoroquinolone antibiotic.
|
|
|
|---|---|
| Fluoroquinolones | Ciprofloxacin, Enoxacin, Fleroxacin, Gatifloxacin, Gemifloxacin, Grepafloxacin, Levofloxacin, Lomefloxacin, Moxifloxacin, Norfloxacin, Ofloxacin, Pefloxacin, Prulifloxacin, Rufloxacin, Sparfloxacin, Temafloxacin, Trovafloxacin, Sitafloxacin |
| Other quinolones | Cinoxacin, Flumequine, Nalidixic acid, Oxolinic acid, Pipemidic acid, Piromidic acid, Rosoxacin |
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
